Tumor dormancy and oncogene addictionFELSHER, Dean W.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2008, Vol 116, Num 7-8, pp 629-637, issn 0903-4641, 9 p.Article

Overexpressed HER2 in NSCLC is a Possible Therapeutic Target of EGFR InhibitorsISE, Nobuyuki; OMI, Kazuya; NAMBARA, Daisuke et al.Anticancer research. 2011, Vol 31, Num 12, pp 4155-4161, issn 0250-7005, 7 p.Article

Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cellsWANG, Y; NGO, V. N; MARANI, M et al.Oncogene (Basingstoke). 2010, Vol 29, Num 33, pp 4658-4670, issn 0950-9232, 13 p.Article

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLCOU, S.-H. I; JÄNNE, P. A; RIELY, G. J et al.Annals of oncology. 2014, Vol 25, Num 2, pp 415-422, issn 0923-7534, 8 p.Article

Targeting molecular addictions in cancerVIVANCO, I.British journal of cancer. 2014, Vol 111, Num 11, pp 2033-2038, issn 0007-0920, 6 p.Article

Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical PerformanceLEVITZKI, Alexander.Annual review of pharmacology and toxicology (Print). 2013, Vol 53, pp 161-185, issn 0362-1642, 25 p.Article

A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumorsTORTI, Davide; SASSI, Francesco; GALIMI, Francesco et al.International journal of cancer (Print). 2012, Vol 130, Num 6, pp 1357-1366, issn 0020-7136, 10 p.Article

Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYCHOLIEN, T; VATSVEEN, T. K; SUNDAN, A et al.Leukemia. 2012, Vol 26, Num 5, pp 1073-1080, issn 0887-6924, 8 p.Article

Exploiting the balance between life and death: Targeted cancer therapy and oncogenic shockSHARMA, Sreenath V; SETTLEMAN, Jeff.Biochemical pharmacology. 2010, Vol 80, Num 5, pp 666-673, issn 0006-2952, 8 p.Article

Signaling Pathways in Hepatocellular CarcinomaSIA, Daniela; VILLANUEVA, Augusto.Oncology. 2011, Vol 81, pp 18-23, issn 0030-2414, 6 p., SUP1Conference Paper

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelMURAKAMI, Toshi; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2014, Vol 83, Num 1, pp 30-36, issn 0169-5002, 7 p.Article

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation : Lung cancerSUDA, Kenichi; TOMIZAWA, Kenji; MITSUDOMI, Tetsuya et al.Cancer metastasis reviews. 2010, Vol 29, Num 1, pp 49-60, issn 0167-7659, 12 p.Article